Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic drug monitoring for cytotoxic anticancer drugs: Principles and evidence-based practices. | Front Oncol | 2022 | 36568145 | PubTator, text mining | PubMed |
| Clinical benefits of oral capecitabine over intravenous 5-fluorouracyl regimen in case of neoadjuvant chemoradiotherapy followed by surgery for locally advanced rectal cancer. | Pathol Oncol Res | 2022 | 36567978 | PubTator, text mining | PubMed |
| Germline genetic variation and predicting immune checkpoint inhibitor induced toxicity. | NPJ Genom Med | 2022 | 36564402 | PubTator, text mining | PubMed |
| Validation of Pharmacogenomic Interaction Probability (PIP) Scores in Predicting Drug-Gene, Drug-Drug-Gene, and Drug-Gene-Gene Interaction Risks in a Large Patient Population. | J Pers Med | 2022 | 36556194 | PubTator, text mining | PubMed |
| Synthesis, characterization, and anticancer evaluation of 1,3-bistetrahydrofuran-2yl-5-FU as a potential agent for pancreatic cancer. | BMC Cancer | 2022 | 36550419 | PubTator, text mining | PubMed |
| Xerogels Morphology Details by Multifractal Analysis and Scanning Electron Microscopy Images Evaluations of 5-Fluorouracil Release from Chitosan-Based Matrix. | Gels | 2022 | 36547344 | PubTator, text mining | PubMed |
| Whole-exome sequencing of a Saudi epilepsy cohort reveals association signals in known and potentially novel loci. | Hum Genomics | 2022 | 36539902 | PubTator, text mining | PubMed |
| Insights into the role of long non-coding RNAs in DNA methylation mediated transcriptional regulation. | Front Mol Biosci | 2022 | 36533073 | PubTator, text mining | PubMed |
| Health-Related Quality of Life of Patients with Metastatic Pancreatic Cancer: A Systematic Literature Review. | Cancer Manag Res | 2022 | 36510575 | PubTator, text mining | PubMed |
| Retroviral Replicating Vector Toca 511 (Vocimagene Amiretrorepvec) for Prodrug Activator Gene Therapy of Lung Cancer. | Cancers (Basel) | 2022 | 36497300 | PubTator, text mining | PubMed |
| Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth. | Elife | 2022 | 36475542 | PubTator, text mining | PubMed |
| A history of cancer and its treatment: Presidential Address to the Ulster Medical Society. 7th October 2021. | Ulster Med J | 2022 | 36474852 | PubTator, text mining | PubMed |
| MagMD: Database summarizing the metabolic action of gut microbiota to drugs. | Comput Struct Biotechnol J | 2022 | 36467581 | PubTator, text mining | PubMed |
| Beneficial effect of pristimerin against the development of osteoporosis in ovariectomy-induced osteoporosis rats by the RANKL/TRAF6/NF-κB pathway. | Arch Med Sci | 2022 | 36457960 | PubTator, text mining | PubMed |
| Antitumor activity of lurbinectedin in combination with oral capecitabine in patients with metastatic breast cancer. | ESMO Open | 2022 | 36455505 | PubTator, text mining | PubMed |
| 5-Fluorouracil and actinomycin D lead to erythema multiforme drug eruption in chemotherapy of invasive mole: Case report and literature review. | Medicine (Baltimore) | 2022 | 36451432 | PubTator, text mining | PubMed |
| Utilization of Drugs with Pharmacogenetic Dosing Recommendations in Switzerland: A Descriptive Study Using the Helsana Database. | Pharmgenomics Pers Med | 2022 | 36447837 | PubTator, text mining | PubMed |
| Editorial: Pharmacogenomics in neglected populations. | Front Pharmacol | 2022 | 36438814 | PubTator, text mining | PubMed |
| Predicting Dihydropyrimidine Dehydrogenase Deficiency and Related 5-Fluorouracil Toxicity: Opportunities and Challenges of DPYD Exon Sequencing and the Role of Phenotyping Assays. | Int J Mol Sci | 2022 | 36430399 | PubTator, text mining | PubMed |
| SNPs in 3'UTR miRNA Target Sequences Associated with Individual Drug Susceptibility. | Int J Mol Sci | 2022 | 36430200 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=35